These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35114680)

  • 1. Neonatal Screening for Congenital Adrenal Hyperplasia in Denmark: 10 Years of Experience.
    Lind-Holst M; Bækvad-Hansen M; Berglund A; Cohen AS; Melgaard L; Skogstrand K; Duno M; Main KM; Hougaard DM; Gravholt CH; Hansen D
    Horm Res Paediatr; 2022; 95(1):35-42. PubMed ID: 35114680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.
    van der Linde AAA; Schönbeck Y; van der Kamp HJ; van den Akker ELT; van Albada ME; Boelen A; Finken MJJ; Hannema SE; Hoorweg-Nijman G; Odink RJ; Schielen PCJI; Straetemans S; van Trotsenburg PS; Claahsen-van der Grinten HL; Verkerk PH
    Arch Dis Child; 2019 Jul; 104(7):653-657. PubMed ID: 30712004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
    Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
    BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
    Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
    Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
    BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
    Thil'en A; Nordenström A; Hagenfeldt L; von Döbeln U; Guthenberg C; Larsson A
    Pediatrics; 1998 Apr; 101(4):E11. PubMed ID: 9521977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
    Cavarzere P; Camilot M; Palma L; Lauriola S; Gaudino R; Vincenzi M; Antoniazzi F; Teofoli F; Piacentini G
    Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A; Cacciari E; Piazzi S; Cassio A; Bozza D; Pirazzoli P; Zappulla F
    Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland.
    Steigert M; Schoenle EJ; Biason-Lauber A; Torresani T
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4106-10. PubMed ID: 12213856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of newborn screening for congenital adrenal hyperplasia.
    Brosnan PG; Brosnan CA; Kemp SF; Domek DB; Jelley DH; Blackett PR; Riley WJ
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1272-8. PubMed ID: 10591305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
    Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
    Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
    Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
    J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Newborn screening for congenital adrenal hyperplasia in France].
    Kariyawasam D; Nguyen-Khoa T; Gonzalez Briceño L; Polak M
    Med Sci (Paris); 2021 May; 37(5):500-506. PubMed ID: 34003096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
    Zetterström RH; Karlsson L; Falhammar H; Lajic S; Nordenström A
    Int J Neonatal Screen; 2020 Aug; 6(3):. PubMed ID: 33239597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in croatia between 1995 and 2006.
    Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
    Horm Res; 2009; 72(5):310-4. PubMed ID: 19844117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.